Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks ResignsInvestors Business Daily • 03/31/25
Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)Seeking Alpha • 03/11/25
Novavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript)Seeking Alpha • 03/04/25
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize ValueBenzinga • 02/27/25
Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsPRNewsWire • 02/27/25
Vaccine Stocks Rise as Chinese Scientists Discover a New CoronavirusZacks Investment Research • 02/24/25
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025PRNewsWire • 02/20/25
Novavax (NVAX) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 02/04/25
Wall Street Analysts Predict an 81.61% Upside in Novavax (NVAX): Here's What You Should KnowZacks Investment Research • 01/22/25